Are Real-Time Trials Leaving Recruitment Behind?

The FDA recently announced real-time clinical trial proof-of-concepts and a proposed pilot program to help trial data and safety signals move faster.

The agency noted that early-phase trials are often slowed by limited patient populations, delayed data flow, and inefficient decision-making.

But faster trial data will not fix slow, fragmented, or volume-first recruitment.

As clinical trials move toward faster execution, recruitment strategies need to keep pace. Sponsors still need a clear way to reach better-fit patients, qualify them earlier, and understand where patient drop-off is happening.

Without that visibility, even a faster trial can lose momentum before patients reach the site.

This brief explains why recruitment readiness matters now and how Antidote helps support stronger patient progression.

Explore Precision Recruitment